FOXA1 mutations alter pioneering activity, differentiation and prostate cancer phenotypes (vol 52, pg 631, 2019)

被引:0
|
作者
Adams, Elizabeth J.
Karthaus, Wouter R.
Hoover, Elizabeth
Liu, Deli
Gruet, Antoine
Zhang, Zeda
Cho, Hyunwoo
DiLoreto, Rose
Chhangawala, Sagar
Liu, Yang
Watson, Philip A.
Davicioni, Elai
Sboner, Andrea
Barbieri, Christopher E.
Bose, Rohit
Leslie, Christina S.
Sawyers, Charles L.
机构
[1] Memorial Sloan Kettering Cancer Center,Human Oncology and Pathogenesis Program
[2] Weill Cornell Medicine,Sandra and Edward Meyer Cancer Center
[3] Weill Cornell Medicine,Department of Urology
[4] Weill Cornell Medical College,HRH Prince Alwaleed Bin Talal Bin Abdulaziz Alsaud Institute for Computational Biomedicine
[5] Memorial Sloan Kettering Cancer Center,Center for Epigenetics Research
[6] Memorial Sloan Kettering Cancer Center,Louis V. Gerstner Jr Graduate School of Biomedical Sciences
[7] Memorial Sloan Kettering Cancer Center,Computational and Systems Biology Program
[8] Weill Cornell Graduate School,Physiology, Biophysics, and Systems Biology Program
[9] Weill Cornell Medicine,Tri
[10] GenomeDx Bioscience,Institutional Training Program in Computational Biology & Medicine
[11] Englander Institute for Precision Medicine of Weill Cornell Medicine and NewYork-Presbyterian Hospital,Departments of Anatomy, Medicine and Urology
[12] University of California,undefined
[13] San Francisco,undefined
[14] Howard Hughes Medical Institute,undefined
关键词
D O I
10.1038/s41586-020-2678-x
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
An amendment to this paper has been published and can be accessed via a link at the top of the paper.
引用
收藏
页码:E20 / E20
页数:1
相关论文
共 50 条
  • [21] Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer
    Kevin J. Tam
    Liangliang Liu
    Michael Hsing
    Kush Dalal
    Daksh Thaper
    Brian McConeghy
    Parvin Yenki
    Satyam Bhasin
    James W. Peacock
    Yuzhuo Wang
    Artem Cherkasov
    Paul S. Rennie
    Martin E. Gleave
    Christopher J. Ong
    [J]. Scientific Reports, 14
  • [22] Clinically-observed FOXA1 mutations upregulate SEMA3C through transcriptional derepression in prostate cancer
    Tam, Kevin J.
    Liu, Liangliang
    Hsing, Michael
    Dalal, Kush
    Thaper, Daksh
    McConeghy, Brian
    Yenki, Parvin
    Bhasin, Satyam
    Peacock, James W.
    Wang, Yuzhuo
    Cherkasov, Artem
    Rennie, Paul S.
    Gleave, Martin E.
    Ong, Christopher J.
    [J]. SCIENTIFIC REPORTS, 2024, 14 (01)
  • [23] SPOP and FOXA1 mutations are associated with PSA recurrence in ERG wt tumors, and SPOP downregulation with ERG-rearranged prostate cancer
    Hernandez-Llodra, Silvia
    Segales, Laura
    Safont, Ainara
    Juanpere, Nuria
    Lorenzo, Marta
    Fumado, Lluis
    Rodriguez-Vida, Alejo
    Cecchini, Lluis
    Bellmunt, Joaquim
    Lloreta-Trull, Josep
    [J]. PROSTATE, 2019, 79 (10): : 1156 - 1165
  • [24] Integrative analysis identifies targetable CREB1/FoxA1 transcriptional co-regulation as a predictor of prostate cancer recurrence (vol 44, pg 4105, 2016)
    Sunkel, Benjamin
    Wu, Dayong
    Chen, Zhong
    Wang, Chiou-Miin
    Liu, Xiangtao
    Ye, Zhenqing
    Horning, Aaron M.
    Liu, Joseph
    Mahalingam, Devalingam
    Lopez-Nicora, Horacio
    Lin, Chun-Lin
    Goodfellow, Paul J.
    Clinton, Steven K.
    Jin, Victor X.
    Chen, Chun-Liang
    Huang, Tim H. -M.
    Wang, Qianben
    [J]. NUCLEIC ACIDS RESEARCH, 2017, 45 (11) : 6993 - 6993
  • [25] Androgen receptor driven transcription in molecular apocrine breast cancer is mediated by FoxA1 (vol 30, pg 3019, 2011)
    Robinson, Jessica L. L.
    MacArthur, Stewart
    Ross-Innes, Caryn S.
    Tilley, Wayne D.
    Neal, David E.
    Mills, Ian G.
    Carroll, Jason S.
    [J]. EMBO JOURNAL, 2012, 31 (06): : 1617 - 1617
  • [26] Convergent CREB1/FoxA1 transcriptional activity defines castration-resistant prostate cancer gene expression profile
    Sunkel, Benjamin D.
    Wu, Dayong
    Liu, Xiangtao
    Ye, Zhenqing
    Jin, Victor
    Wang, Qianben
    [J]. CANCER RESEARCH, 2014, 74 (19)
  • [27] FOXA1 Modulates EAF2 Regulation of AR Transcriptional Activity, Cell Proliferation, and Migration in Prostate Cancer Cells
    Guo, Wenhuan
    Keener, Anne L.
    Jing, Yifeng
    Cai, Liquan
    Ai, Junkui
    Zhang, Jian
    Fu, Guohui
    Wang, Zhou
    [J]. PROSTATE, 2015, 75 (09): : 976 - 987
  • [28] MALAT1 promotes FOXA1 degradation by competitively binding to miR-216a-5p and enhancing neuroendocrine differentiation in prostate cancer
    Zeng, Fanchang
    Li, Daoyuan
    Kang, Xinli
    Wu, Qinghui
    Song, Mi
    Ou, Zhewen
    Yang, Zuobing
    Yang, Jing
    Luo, Liumei
    [J]. TRANSLATIONAL ONCOLOGY, 2024, 39
  • [29] Definition of a FoxA1 Cistrome That Is Crucial for G1 to S-Phase Cell-Cycle Transit in Castration-Resistant Prostate Cancer (vol 71, pg 6738, 2011)
    Zhang, C.
    Wang, L.
    Wu, D.
    Chen, H.
    Thomas-Ahner, J.M.
    [J]. CANCER RESEARCH, 2011, 71 (24) : 7718 - 7718
  • [30] Epigenetic Therapy with Panobinostat Combined with Bicalutamide Rechallenge in Castration-Resistant Prostate Cancer (vol 25, pg 52, 2019)
    Ferrari, Anna C.
    Alumkal, Joshi J.
    Stein, Mark N.
    Taplin, Mary-Ellen
    Babb, James
    Barnett, Ethan S.
    Gomez-Pinillos, Alejandro
    Liu, Xiaomei
    Moore, Dirk
    DiPaola, Robert
    Beer, Tomasz M.
    [J]. CLINICAL CANCER RESEARCH, 2019, 25 (08) : 2672 - 2672